ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Engineering State-of-the-Art Plasmonic Nanomaterials for SERS-Based Clinical Liquid Biopsy Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019Review
- Microslit on a chip: A simplified filter to capture circulating tumor cells enlarged with microbeads.PloS one · 2019Article
- EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression.Oncotarget · 2017Article
- Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro.In vitro cellular & developmental biology. Animal · 2017Article
- Liquid biopsy: a step forward towards precision medicine in urologic malignancies.Molecular cancer · 2017Review
- Tissue-based biomarkers in prostate cancer.Expert review of precision medicine and drug development · 2017Article
- Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.BioMed research international · 2017Review
- Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.International journal of molecular sciences · 2016Review
- Circulating tumor cells in germ cell tumors: are those biomarkers of real prognostic value? A review.Clujul medical (1957) · 2016Review
- Emerging role of circulating tumor cells in cancer management.Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology · 2014Article
- Molecular pathways and targets in prostate cancer.Oncotarget · 2014Review
- Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2014Article
Corrections and comments
- Comment on
- Erratum issued
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24616311What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.